nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER2—prostate gland—prostate cancer	0.0187	0.124	CbGeAlD
Misoprostol—PTGER4—prostate gland—prostate cancer	0.0184	0.121	CbGeAlD
Misoprostol—PTGER3—prostate gland—prostate cancer	0.0155	0.103	CbGeAlD
Misoprostol—PTGER4—epithelium—prostate cancer	0.0135	0.0891	CbGeAlD
Misoprostol—Lubiprostone—CBR1—prostate cancer	0.013	0.811	CrCbGaD
Misoprostol—PTGER2—urethra—prostate cancer	0.0125	0.0827	CbGeAlD
Misoprostol—PTGER4—renal system—prostate cancer	0.0125	0.0827	CbGeAlD
Misoprostol—PTGER3—renal system—prostate cancer	0.0106	0.07	CbGeAlD
Misoprostol—PTGER2—bone marrow—prostate cancer	0.00964	0.0637	CbGeAlD
Misoprostol—PTGER2—testis—prostate cancer	0.00824	0.0544	CbGeAlD
Misoprostol—PTGER4—testis—prostate cancer	0.00809	0.0534	CbGeAlD
Misoprostol—PTGER3—testis—prostate cancer	0.00685	0.0453	CbGeAlD
Misoprostol—PTGER2—lymph node—prostate cancer	0.00597	0.0395	CbGeAlD
Misoprostol—PTGER4—lymph node—prostate cancer	0.00586	0.0387	CbGeAlD
Misoprostol—PTGER3—lymph node—prostate cancer	0.00496	0.0328	CbGeAlD
Misoprostol—Dinoprostone—HPGDS—prostate cancer	0.00175	0.109	CrCbGaD
Misoprostol—Dinoprostone—SLC22A1—prostate cancer	0.000732	0.0455	CrCbGaD
Misoprostol—Dinoprostone—CYP19A1—prostate cancer	0.000544	0.0339	CrCbGaD
Misoprostol—Hypersensitivity—Estradiol—prostate cancer	0.000203	0.000386	CcSEcCtD
Misoprostol—Abdominal pain—Mitoxantrone—prostate cancer	0.000203	0.000386	CcSEcCtD
Misoprostol—Body temperature increased—Mitoxantrone—prostate cancer	0.000203	0.000386	CcSEcCtD
Misoprostol—Bronchitis—Epirubicin—prostate cancer	0.000202	0.000385	CcSEcCtD
Misoprostol—Muscle spasms—Capecitabine—prostate cancer	0.000202	0.000385	CcSEcCtD
Misoprostol—Anaemia—Docetaxel—prostate cancer	0.000201	0.000382	CcSEcCtD
Misoprostol—Hypotension—Etoposide—prostate cancer	0.000199	0.00038	CcSEcCtD
Misoprostol—Asthenia—Estradiol—prostate cancer	0.000198	0.000376	CcSEcCtD
Misoprostol—Dysuria—Epirubicin—prostate cancer	0.000197	0.000374	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000196	0.000372	CcSEcCtD
Misoprostol—Syncope—Docetaxel—prostate cancer	0.000195	0.000371	CcSEcCtD
Misoprostol—Dysphagia—Doxorubicin—prostate cancer	0.000195	0.00037	CcSEcCtD
Misoprostol—Anaemia—Capecitabine—prostate cancer	0.000194	0.00037	CcSEcCtD
Misoprostol—Immune system disorder—Prednisone—prostate cancer	0.000194	0.00037	CcSEcCtD
Misoprostol—Arrhythmia—Prednisone—prostate cancer	0.000192	0.000366	CcSEcCtD
Misoprostol—Loss of consciousness—Docetaxel—prostate cancer	0.000191	0.000364	CcSEcCtD
Misoprostol—Dyspnoea—Etoposide—prostate cancer	0.00019	0.000362	CcSEcCtD
Misoprostol—Alopecia—Prednisone—prostate cancer	0.00019	0.000362	CcSEcCtD
Misoprostol—Somnolence—Etoposide—prostate cancer	0.00019	0.000361	CcSEcCtD
Misoprostol—Hypersensitivity—Mitoxantrone—prostate cancer	0.000189	0.00036	CcSEcCtD
Misoprostol—Syncope—Capecitabine—prostate cancer	0.000189	0.000359	CcSEcCtD
Misoprostol—Pneumonia—Epirubicin—prostate cancer	0.000189	0.000359	CcSEcCtD
Misoprostol—Diarrhoea—Estradiol—prostate cancer	0.000188	0.000359	CcSEcCtD
Misoprostol—Hypertension—Docetaxel—prostate cancer	0.000188	0.000357	CcSEcCtD
Misoprostol—Drowsiness—Epirubicin—prostate cancer	0.000188	0.000357	CcSEcCtD
Misoprostol—Bronchitis—Doxorubicin—prostate cancer	0.000187	0.000356	CcSEcCtD
Misoprostol—Myalgia—Docetaxel—prostate cancer	0.000185	0.000352	CcSEcCtD
Misoprostol—Chest pain—Docetaxel—prostate cancer	0.000185	0.000352	CcSEcCtD
Misoprostol—Arthralgia—Docetaxel—prostate cancer	0.000185	0.000352	CcSEcCtD
Misoprostol—Loss of consciousness—Capecitabine—prostate cancer	0.000185	0.000352	CcSEcCtD
Misoprostol—Asthenia—Mitoxantrone—prostate cancer	0.000184	0.00035	CcSEcCtD
Misoprostol—Fatigue—Etoposide—prostate cancer	0.000184	0.00035	CcSEcCtD
Misoprostol—Neuropathy peripheral—Epirubicin—prostate cancer	0.000184	0.00035	CcSEcCtD
Misoprostol—Pain—Etoposide—prostate cancer	0.000183	0.000347	CcSEcCtD
Misoprostol—Constipation—Etoposide—prostate cancer	0.000183	0.000347	CcSEcCtD
Misoprostol—Conjunctivitis—Epirubicin—prostate cancer	0.000182	0.000347	CcSEcCtD
Misoprostol—Urinary tract infection—Epirubicin—prostate cancer	0.000182	0.000347	CcSEcCtD
Misoprostol—Dizziness—Estradiol—prostate cancer	0.000182	0.000347	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—prostate cancer	0.000182	0.000346	CcSEcCtD
Misoprostol—Hypertension—Capecitabine—prostate cancer	0.000182	0.000346	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000181	0.000344	CcSEcCtD
Misoprostol—Chest pain—Capecitabine—prostate cancer	0.000179	0.000341	CcSEcCtD
Misoprostol—Arthralgia—Capecitabine—prostate cancer	0.000179	0.000341	CcSEcCtD
Misoprostol—Myalgia—Capecitabine—prostate cancer	0.000179	0.000341	CcSEcCtD
Misoprostol—Haematuria—Epirubicin—prostate cancer	0.000179	0.00034	CcSEcCtD
Misoprostol—Confusional state—Docetaxel—prostate cancer	0.000179	0.00034	CcSEcCtD
Misoprostol—Anxiety—Capecitabine—prostate cancer	0.000179	0.00034	CcSEcCtD
Misoprostol—Oedema—Docetaxel—prostate cancer	0.000177	0.000338	CcSEcCtD
Misoprostol—Anaphylactic shock—Docetaxel—prostate cancer	0.000177	0.000338	CcSEcCtD
Misoprostol—Epistaxis—Epirubicin—prostate cancer	0.000177	0.000337	CcSEcCtD
Misoprostol—Infection—Docetaxel—prostate cancer	0.000176	0.000335	CcSEcCtD
Misoprostol—Feeling abnormal—Etoposide—prostate cancer	0.000176	0.000335	CcSEcCtD
Misoprostol—Diarrhoea—Mitoxantrone—prostate cancer	0.000176	0.000334	CcSEcCtD
Misoprostol—Vomiting—Estradiol—prostate cancer	0.000175	0.000333	CcSEcCtD
Misoprostol—Pneumonia—Doxorubicin—prostate cancer	0.000175	0.000332	CcSEcCtD
Misoprostol—Gastrointestinal pain—Etoposide—prostate cancer	0.000175	0.000332	CcSEcCtD
Misoprostol—Shock—Docetaxel—prostate cancer	0.000175	0.000332	CcSEcCtD
Misoprostol—Thrombocytopenia—Docetaxel—prostate cancer	0.000174	0.000331	CcSEcCtD
Misoprostol—Rash—Estradiol—prostate cancer	0.000174	0.00033	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—prostate cancer	0.000174	0.00033	CcSEcCtD
Misoprostol—Dermatitis—Estradiol—prostate cancer	0.000173	0.00033	CcSEcCtD
Misoprostol—Anaemia—Prednisone—prostate cancer	0.000173	0.00033	CcSEcCtD
Misoprostol—Confusional state—Capecitabine—prostate cancer	0.000173	0.00033	CcSEcCtD
Misoprostol—Headache—Estradiol—prostate cancer	0.000173	0.000328	CcSEcCtD
Misoprostol—Oedema—Capecitabine—prostate cancer	0.000172	0.000327	CcSEcCtD
Misoprostol—Infection—Capecitabine—prostate cancer	0.000171	0.000325	CcSEcCtD
Misoprostol—Neuropathy peripheral—Doxorubicin—prostate cancer	0.00017	0.000324	CcSEcCtD
Misoprostol—Shock—Capecitabine—prostate cancer	0.000169	0.000322	CcSEcCtD
Misoprostol—Abdominal pain—Etoposide—prostate cancer	0.000169	0.000321	CcSEcCtD
Misoprostol—Body temperature increased—Etoposide—prostate cancer	0.000169	0.000321	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—prostate cancer	0.000169	0.000321	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—prostate cancer	0.000169	0.000321	CcSEcCtD
Misoprostol—Thrombocytopenia—Capecitabine—prostate cancer	0.000168	0.00032	CcSEcCtD
Misoprostol—Syncope—Prednisone—prostate cancer	0.000168	0.00032	CcSEcCtD
Misoprostol—Hyperhidrosis—Capecitabine—prostate cancer	0.000166	0.000316	CcSEcCtD
Misoprostol—Hypotension—Docetaxel—prostate cancer	0.000166	0.000315	CcSEcCtD
Misoprostol—Haematuria—Doxorubicin—prostate cancer	0.000165	0.000315	CcSEcCtD
Misoprostol—Loss of consciousness—Prednisone—prostate cancer	0.000165	0.000314	CcSEcCtD
Misoprostol—Epistaxis—Doxorubicin—prostate cancer	0.000164	0.000312	CcSEcCtD
Misoprostol—Nausea—Estradiol—prostate cancer	0.000164	0.000311	CcSEcCtD
Misoprostol—Vomiting—Mitoxantrone—prostate cancer	0.000163	0.000311	CcSEcCtD
Misoprostol—Visual impairment—Epirubicin—prostate cancer	0.000162	0.000309	CcSEcCtD
Misoprostol—Hypertension—Prednisone—prostate cancer	0.000162	0.000308	CcSEcCtD
Misoprostol—Rash—Mitoxantrone—prostate cancer	0.000162	0.000308	CcSEcCtD
Misoprostol—Dermatitis—Mitoxantrone—prostate cancer	0.000162	0.000308	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000162	0.000308	CcSEcCtD
Misoprostol—Headache—Mitoxantrone—prostate cancer	0.000161	0.000306	CcSEcCtD
Misoprostol—Hypotension—Capecitabine—prostate cancer	0.00016	0.000305	CcSEcCtD
Misoprostol—Myalgia—Prednisone—prostate cancer	0.00016	0.000304	CcSEcCtD
Misoprostol—Arthralgia—Prednisone—prostate cancer	0.00016	0.000304	CcSEcCtD
Misoprostol—Anxiety—Prednisone—prostate cancer	0.000159	0.000303	CcSEcCtD
Misoprostol—Dyspnoea—Docetaxel—prostate cancer	0.000158	0.000301	CcSEcCtD
Misoprostol—Somnolence—Docetaxel—prostate cancer	0.000158	0.0003	CcSEcCtD
Misoprostol—Hypersensitivity—Etoposide—prostate cancer	0.000157	0.000299	CcSEcCtD
Misoprostol—Tinnitus—Epirubicin—prostate cancer	0.000157	0.000299	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000156	0.000298	CcSEcCtD
Misoprostol—Dyspepsia—Docetaxel—prostate cancer	0.000156	0.000297	CcSEcCtD
Misoprostol—Asthenia—Etoposide—prostate cancer	0.000153	0.000291	CcSEcCtD
Misoprostol—Dyspnoea—Capecitabine—prostate cancer	0.000153	0.000291	CcSEcCtD
Misoprostol—Anaphylactic shock—Prednisone—prostate cancer	0.000153	0.000291	CcSEcCtD
Misoprostol—Oedema—Prednisone—prostate cancer	0.000153	0.000291	CcSEcCtD
Misoprostol—Fatigue—Docetaxel—prostate cancer	0.000153	0.000291	CcSEcCtD
Misoprostol—Nausea—Mitoxantrone—prostate cancer	0.000152	0.00029	CcSEcCtD
Misoprostol—Immune system disorder—Epirubicin—prostate cancer	0.000152	0.000289	CcSEcCtD
Misoprostol—Infection—Prednisone—prostate cancer	0.000152	0.000289	CcSEcCtD
Misoprostol—Pain—Docetaxel—prostate cancer	0.000152	0.000289	CcSEcCtD
Misoprostol—Constipation—Docetaxel—prostate cancer	0.000152	0.000289	CcSEcCtD
Misoprostol—Dyspepsia—Capecitabine—prostate cancer	0.000151	0.000288	CcSEcCtD
Misoprostol—Chills—Epirubicin—prostate cancer	0.000151	0.000288	CcSEcCtD
Misoprostol—Shock—Prednisone—prostate cancer	0.00015	0.000286	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—prostate cancer	0.00015	0.000286	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—prostate cancer	0.00015	0.000286	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—prostate cancer	0.000149	0.000283	CcSEcCtD
Misoprostol—Fatigue—Capecitabine—prostate cancer	0.000148	0.000282	CcSEcCtD
Misoprostol—Hyperhidrosis—Prednisone—prostate cancer	0.000148	0.000281	CcSEcCtD
Misoprostol—Pain—Capecitabine—prostate cancer	0.000147	0.00028	CcSEcCtD
Misoprostol—Constipation—Capecitabine—prostate cancer	0.000147	0.00028	CcSEcCtD
Misoprostol—Feeling abnormal—Docetaxel—prostate cancer	0.000146	0.000278	CcSEcCtD
Misoprostol—Diarrhoea—Etoposide—prostate cancer	0.000146	0.000278	CcSEcCtD
Misoprostol—Tinnitus—Doxorubicin—prostate cancer	0.000145	0.000276	CcSEcCtD
Misoprostol—Gastrointestinal pain—Docetaxel—prostate cancer	0.000145	0.000276	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—prostate cancer	0.000144	0.000275	CcSEcCtD
Misoprostol—Back pain—Epirubicin—prostate cancer	0.000142	0.00027	CcSEcCtD
Misoprostol—Feeling abnormal—Capecitabine—prostate cancer	0.000142	0.000269	CcSEcCtD
Misoprostol—Dizziness—Etoposide—prostate cancer	0.000141	0.000269	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—prostate cancer	0.000141	0.000268	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—prostate cancer	0.000141	0.000268	CcSEcCtD
Misoprostol—Gastrointestinal pain—Capecitabine—prostate cancer	0.00014	0.000267	CcSEcCtD
Misoprostol—Abdominal pain—Docetaxel—prostate cancer	0.00014	0.000267	CcSEcCtD
Misoprostol—Body temperature increased—Docetaxel—prostate cancer	0.00014	0.000267	CcSEcCtD
Misoprostol—Chills—Doxorubicin—prostate cancer	0.00014	0.000266	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000139	0.000265	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—prostate cancer	0.000139	0.000265	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—prostate cancer	0.000138	0.000262	CcSEcCtD
Misoprostol—Body temperature increased—Capecitabine—prostate cancer	0.000136	0.000258	CcSEcCtD
Misoprostol—Abdominal pain—Capecitabine—prostate cancer	0.000136	0.000258	CcSEcCtD
Misoprostol—Vomiting—Etoposide—prostate cancer	0.000136	0.000258	CcSEcCtD
Misoprostol—Anaemia—Epirubicin—prostate cancer	0.000135	0.000258	CcSEcCtD
Misoprostol—Dyspepsia—Prednisone—prostate cancer	0.000135	0.000256	CcSEcCtD
Misoprostol—Rash—Etoposide—prostate cancer	0.000135	0.000256	CcSEcCtD
Misoprostol—Dermatitis—Etoposide—prostate cancer	0.000134	0.000256	CcSEcCtD
Misoprostol—Headache—Etoposide—prostate cancer	0.000134	0.000254	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—prostate cancer	0.000134	0.000254	CcSEcCtD
Misoprostol—Fatigue—Prednisone—prostate cancer	0.000132	0.000251	CcSEcCtD
Misoprostol—Syncope—Epirubicin—prostate cancer	0.000131	0.00025	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—prostate cancer	0.000131	0.00025	CcSEcCtD
Misoprostol—Constipation—Prednisone—prostate cancer	0.000131	0.000249	CcSEcCtD
Misoprostol—Hypersensitivity—Docetaxel—prostate cancer	0.000131	0.000249	CcSEcCtD
Misoprostol—Muscle spasms—Doxorubicin—prostate cancer	0.00013	0.000248	CcSEcCtD
Misoprostol—Loss of consciousness—Epirubicin—prostate cancer	0.000129	0.000245	CcSEcCtD
Misoprostol—Asthenia—Docetaxel—prostate cancer	0.000127	0.000242	CcSEcCtD
Misoprostol—Nausea—Etoposide—prostate cancer	0.000127	0.000241	CcSEcCtD
Misoprostol—Hypertension—Epirubicin—prostate cancer	0.000127	0.000241	CcSEcCtD
Misoprostol—Hypersensitivity—Capecitabine—prostate cancer	0.000127	0.000241	CcSEcCtD
Misoprostol—Feeling abnormal—Prednisone—prostate cancer	0.000126	0.00024	CcSEcCtD
Misoprostol—Anaemia—Doxorubicin—prostate cancer	0.000125	0.000239	CcSEcCtD
Misoprostol—Gastrointestinal pain—Prednisone—prostate cancer	0.000125	0.000238	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—prostate cancer	0.000125	0.000238	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—prostate cancer	0.000125	0.000238	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—prostate cancer	0.000125	0.000238	CcSEcCtD
Misoprostol—Anxiety—Epirubicin—prostate cancer	0.000124	0.000237	CcSEcCtD
Misoprostol—Asthenia—Capecitabine—prostate cancer	0.000123	0.000235	CcSEcCtD
Misoprostol—Syncope—Doxorubicin—prostate cancer	0.000122	0.000232	CcSEcCtD
Misoprostol—Diarrhoea—Docetaxel—prostate cancer	0.000121	0.000231	CcSEcCtD
Misoprostol—Abdominal pain—Prednisone—prostate cancer	0.000121	0.00023	CcSEcCtD
Misoprostol—Body temperature increased—Prednisone—prostate cancer	0.000121	0.00023	CcSEcCtD
Misoprostol—Confusional state—Epirubicin—prostate cancer	0.000121	0.00023	CcSEcCtD
Misoprostol—Oedema—Epirubicin—prostate cancer	0.00012	0.000228	CcSEcCtD
Misoprostol—Anaphylactic shock—Epirubicin—prostate cancer	0.00012	0.000228	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—prostate cancer	0.000119	0.000227	CcSEcCtD
Misoprostol—Infection—Epirubicin—prostate cancer	0.000119	0.000226	CcSEcCtD
Misoprostol—Shock—Epirubicin—prostate cancer	0.000118	0.000224	CcSEcCtD
Misoprostol—Diarrhoea—Capecitabine—prostate cancer	0.000118	0.000224	CcSEcCtD
Misoprostol—Dizziness—Docetaxel—prostate cancer	0.000117	0.000223	CcSEcCtD
Misoprostol—Thrombocytopenia—Epirubicin—prostate cancer	0.000117	0.000223	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—prostate cancer	0.000117	0.000223	CcSEcCtD
Misoprostol—Hyperhidrosis—Epirubicin—prostate cancer	0.000116	0.00022	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—prostate cancer	0.000115	0.00022	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—prostate cancer	0.000115	0.00022	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—prostate cancer	0.000115	0.00022	CcSEcCtD
Misoprostol—Anxiety—Doxorubicin—prostate cancer	0.000115	0.000219	CcSEcCtD
Misoprostol—Dizziness—Capecitabine—prostate cancer	0.000114	0.000216	CcSEcCtD
Misoprostol—Vomiting—Docetaxel—prostate cancer	0.000113	0.000215	CcSEcCtD
Misoprostol—Hypersensitivity—Prednisone—prostate cancer	0.000113	0.000214	CcSEcCtD
Misoprostol—Rash—Docetaxel—prostate cancer	0.000112	0.000213	CcSEcCtD
Misoprostol—Hypotension—Epirubicin—prostate cancer	0.000112	0.000213	CcSEcCtD
Misoprostol—Dermatitis—Docetaxel—prostate cancer	0.000112	0.000213	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—prostate cancer	0.000112	0.000212	CcSEcCtD
Misoprostol—Headache—Docetaxel—prostate cancer	0.000111	0.000211	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—prostate cancer	0.000111	0.000211	CcSEcCtD
Misoprostol—Anaphylactic shock—Doxorubicin—prostate cancer	0.000111	0.000211	CcSEcCtD
Misoprostol—Infection—Doxorubicin—prostate cancer	0.00011	0.000209	CcSEcCtD
Misoprostol—Asthenia—Prednisone—prostate cancer	0.00011	0.000209	CcSEcCtD
Misoprostol—Vomiting—Capecitabine—prostate cancer	0.000109	0.000208	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000109	0.000207	CcSEcCtD
Misoprostol—Shock—Doxorubicin—prostate cancer	0.000109	0.000207	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—prostate cancer	0.000108	0.000206	CcSEcCtD
Misoprostol—Rash—Capecitabine—prostate cancer	0.000108	0.000206	CcSEcCtD
Misoprostol—Dermatitis—Capecitabine—prostate cancer	0.000108	0.000206	CcSEcCtD
Misoprostol—Headache—Capecitabine—prostate cancer	0.000108	0.000205	CcSEcCtD
Misoprostol—Hyperhidrosis—Doxorubicin—prostate cancer	0.000107	0.000204	CcSEcCtD
Misoprostol—Dyspnoea—Epirubicin—prostate cancer	0.000107	0.000203	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—prostate cancer	0.000106	0.000202	CcSEcCtD
Misoprostol—Nausea—Docetaxel—prostate cancer	0.000105	0.000201	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—prostate cancer	0.000105	0.0002	CcSEcCtD
Misoprostol—Diarrhoea—Prednisone—prostate cancer	0.000105	0.000199	CcSEcCtD
Misoprostol—Hypotension—Doxorubicin—prostate cancer	0.000103	0.000197	CcSEcCtD
Misoprostol—Fatigue—Epirubicin—prostate cancer	0.000103	0.000196	CcSEcCtD
Misoprostol—Pain—Epirubicin—prostate cancer	0.000102	0.000195	CcSEcCtD
Misoprostol—Constipation—Epirubicin—prostate cancer	0.000102	0.000195	CcSEcCtD
Misoprostol—Nausea—Capecitabine—prostate cancer	0.000102	0.000194	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PRKCZ—prostate cancer	0.000101	0.00033	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTHLH—prostate cancer	0.000101	0.00033	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFBR1—prostate cancer	0.000101	0.00033	CbGpPWpGaD
Misoprostol—Dizziness—Prednisone—prostate cancer	0.000101	0.000193	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000101	0.000192	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FGF10—prostate cancer	9.98e-05	0.000325	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKR1C3—prostate cancer	9.98e-05	0.000325	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PRKACB—prostate cancer	9.92e-05	0.000323	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CG—prostate cancer	9.91e-05	0.000323	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ADRB2—prostate cancer	9.87e-05	0.000321	CbGpPWpGaD
Misoprostol—Dyspnoea—Doxorubicin—prostate cancer	9.87e-05	0.000188	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—prostate cancer	9.86e-05	0.000188	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—prostate cancer	9.84e-05	0.000187	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—FGFR4—prostate cancer	9.79e-05	0.000319	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PARP1—prostate cancer	9.79e-05	0.000319	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Epirubicin—prostate cancer	9.78e-05	0.000186	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—prostate cancer	9.74e-05	0.000185	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—JAK2—prostate cancer	9.74e-05	0.000317	CbGpPWpGaD
Misoprostol—Vomiting—Prednisone—prostate cancer	9.73e-05	0.000185	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—MAP2K1—prostate cancer	9.7e-05	0.000316	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PPP3CA—prostate cancer	9.67e-05	0.000315	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—THBS1—prostate cancer	9.67e-05	0.000315	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CALCA—prostate cancer	9.67e-05	0.000315	CbGpPWpGaD
Misoprostol—Rash—Prednisone—prostate cancer	9.65e-05	0.000184	CcSEcCtD
Misoprostol—Dermatitis—Prednisone—prostate cancer	9.64e-05	0.000183	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CD—prostate cancer	9.63e-05	0.000314	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VAV3—prostate cancer	9.63e-05	0.000313	CbGpPWpGaD
Misoprostol—Headache—Prednisone—prostate cancer	9.58e-05	0.000182	CcSEcCtD
Misoprostol—Fatigue—Doxorubicin—prostate cancer	9.54e-05	0.000182	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ANXA1—prostate cancer	9.53e-05	0.00031	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFBR2—prostate cancer	9.49e-05	0.000309	CbGpPWpGaD
Misoprostol—Constipation—Doxorubicin—prostate cancer	9.47e-05	0.00018	CcSEcCtD
Misoprostol—Pain—Doxorubicin—prostate cancer	9.47e-05	0.00018	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—prostate cancer	9.46e-05	0.00018	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—prostate cancer	9.46e-05	0.00018	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CXCL12—prostate cancer	9.45e-05	0.000308	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PRKCZ—prostate cancer	9.36e-05	0.000305	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ITPR1—prostate cancer	9.34e-05	0.000304	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CB—prostate cancer	9.25e-05	0.000301	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CG—prostate cancer	9.15e-05	0.000298	CbGpPWpGaD
Misoprostol—Feeling abnormal—Doxorubicin—prostate cancer	9.12e-05	0.000174	CcSEcCtD
Misoprostol—Nausea—Prednisone—prostate cancer	9.09e-05	0.000173	CcSEcCtD
Misoprostol—Gastrointestinal pain—Doxorubicin—prostate cancer	9.05e-05	0.000172	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FGFR4—prostate cancer	9.04e-05	0.000294	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PARP1—prostate cancer	9.04e-05	0.000294	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CG—prostate cancer	9e-05	0.000293	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF1R—prostate cancer	8.93e-05	0.000291	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CALCA—prostate cancer	8.93e-05	0.000291	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CASP9—prostate cancer	8.9e-05	0.00029	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL8—prostate cancer	8.89e-05	0.000289	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—JAK2—prostate cancer	8.84e-05	0.000288	CbGpPWpGaD
Misoprostol—Hypersensitivity—Epirubicin—prostate cancer	8.81e-05	0.000168	CcSEcCtD
Misoprostol—Body temperature increased—Doxorubicin—prostate cancer	8.75e-05	0.000167	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—prostate cancer	8.75e-05	0.000167	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CXCL12—prostate cancer	8.72e-05	0.000284	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CD—prostate cancer	8.71e-05	0.000284	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PRKCQ—prostate cancer	8.62e-05	0.000281	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NGFR—prostate cancer	8.62e-05	0.000281	CbGpPWpGaD
Misoprostol—Asthenia—Epirubicin—prostate cancer	8.58e-05	0.000163	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—LPL—prostate cancer	8.56e-05	0.000279	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAP3K7—prostate cancer	8.52e-05	0.000277	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—IL2—prostate cancer	8.49e-05	0.000276	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PDGFRB—prostate cancer	8.48e-05	0.000276	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CB—prostate cancer	8.4e-05	0.000273	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CG—prostate cancer	8.31e-05	0.00027	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ITGB3—prostate cancer	8.27e-05	0.000269	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CASP9—prostate cancer	8.21e-05	0.000267	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGF10—prostate cancer	8.19e-05	0.000267	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—prostate cancer	8.19e-05	0.000156	CcSEcCtD
Misoprostol—Hypersensitivity—Doxorubicin—prostate cancer	8.16e-05	0.000155	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—ADRB2—prostate cancer	8.11e-05	0.000264	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCL8—prostate cancer	8.07e-05	0.000263	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CD—prostate cancer	8.04e-05	0.000262	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB3—prostate cancer	8.02e-05	0.000261	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGFR2—prostate cancer	8.01e-05	0.000261	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—JAK2—prostate cancer	8e-05	0.00026	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MAP2K1—prostate cancer	7.96e-05	0.000259	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NGFR—prostate cancer	7.96e-05	0.000259	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PRKCQ—prostate cancer	7.96e-05	0.000259	CbGpPWpGaD
Misoprostol—Asthenia—Doxorubicin—prostate cancer	7.94e-05	0.000151	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CD—prostate cancer	7.91e-05	0.000258	CbGpPWpGaD
Misoprostol—Dizziness—Epirubicin—prostate cancer	7.91e-05	0.000151	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—VAV3—prostate cancer	7.9e-05	0.000257	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAP3K7—prostate cancer	7.86e-05	0.000256	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFBR2—prostate cancer	7.79e-05	0.000254	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL2—prostate cancer	7.71e-05	0.000251	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TERT—prostate cancer	7.68e-05	0.00025	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ITPR1—prostate cancer	7.67e-05	0.00025	CbGpPWpGaD
Misoprostol—Vomiting—Epirubicin—prostate cancer	7.61e-05	0.000145	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CB—prostate cancer	7.59e-05	0.000247	CbGpPWpGaD
Misoprostol—Diarrhoea—Doxorubicin—prostate cancer	7.57e-05	0.000144	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FGF10—prostate cancer	7.56e-05	0.000246	CbGpPWpGaD
Misoprostol—Rash—Epirubicin—prostate cancer	7.54e-05	0.000144	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—prostate cancer	7.54e-05	0.000143	CcSEcCtD
Misoprostol—Headache—Epirubicin—prostate cancer	7.49e-05	0.000143	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ADRB2—prostate cancer	7.48e-05	0.000243	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—JAK2—prostate cancer	7.38e-05	0.00024	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—MAP2K1—prostate cancer	7.35e-05	0.000239	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HIF1A—prostate cancer	7.35e-05	0.000239	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1R—prostate cancer	7.33e-05	0.000239	CbGpPWpGaD
Misoprostol—Dizziness—Doxorubicin—prostate cancer	7.32e-05	0.000139	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CD—prostate cancer	7.3e-05	0.000238	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL8—prostate cancer	7.3e-05	0.000238	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VAV3—prostate cancer	7.29e-05	0.000237	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—JAK2—prostate cancer	7.26e-05	0.000236	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFBR2—prostate cancer	7.19e-05	0.000234	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LEP—prostate cancer	7.17e-05	0.000234	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CAV1—prostate cancer	7.11e-05	0.000231	CbGpPWpGaD
Misoprostol—Nausea—Epirubicin—prostate cancer	7.11e-05	0.000135	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—ITPR1—prostate cancer	7.08e-05	0.00023	CbGpPWpGaD
Misoprostol—Vomiting—Doxorubicin—prostate cancer	7.04e-05	0.000134	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—KDR—prostate cancer	7.03e-05	0.000229	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LPL—prostate cancer	7.03e-05	0.000229	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CB—prostate cancer	7.01e-05	0.000228	CbGpPWpGaD
Misoprostol—Rash—Doxorubicin—prostate cancer	6.98e-05	0.000133	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—IL2—prostate cancer	6.97e-05	0.000227	CbGpPWpGaD
Misoprostol—Dermatitis—Doxorubicin—prostate cancer	6.97e-05	0.000133	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PDGFRB—prostate cancer	6.97e-05	0.000227	CbGpPWpGaD
Misoprostol—Headache—Doxorubicin—prostate cancer	6.93e-05	0.000132	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CB—prostate cancer	6.9e-05	0.000224	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ESR1—prostate cancer	6.85e-05	0.000223	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ITGB3—prostate cancer	6.79e-05	0.000221	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1R—prostate cancer	6.77e-05	0.00022	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL8—prostate cancer	6.73e-05	0.000219	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—JAK2—prostate cancer	6.7e-05	0.000218	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BAD—prostate cancer	6.68e-05	0.000218	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL8—prostate cancer	6.63e-05	0.000216	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB3—prostate cancer	6.58e-05	0.000214	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—prostate cancer	6.58e-05	0.000125	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—FGFR2—prostate cancer	6.57e-05	0.000214	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LPL—prostate cancer	6.49e-05	0.000211	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APC—prostate cancer	6.47e-05	0.000211	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CG—prostate cancer	6.47e-05	0.000211	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2—prostate cancer	6.44e-05	0.00021	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PDGFRB—prostate cancer	6.43e-05	0.000209	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGF—prostate cancer	6.4e-05	0.000208	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IRS1—prostate cancer	6.4e-05	0.000208	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CB—prostate cancer	6.36e-05	0.000207	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2—prostate cancer	6.33e-05	0.000206	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TERT—prostate cancer	6.31e-05	0.000205	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ITGB3—prostate cancer	6.26e-05	0.000204	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—GSK3B—prostate cancer	6.21e-05	0.000202	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—INS—prostate cancer	6.13e-05	0.000199	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCL8—prostate cancer	6.12e-05	0.000199	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB3—prostate cancer	6.08e-05	0.000198	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGFR2—prostate cancer	6.07e-05	0.000197	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HIF1A—prostate cancer	6.03e-05	0.000196	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CREBBP—prostate cancer	6e-05	0.000195	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF1—prostate cancer	5.93e-05	0.000193	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—EGFR—prostate cancer	5.9e-05	0.000192	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LEP—prostate cancer	5.89e-05	0.000192	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL2—prostate cancer	5.84e-05	0.00019	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CAV1—prostate cancer	5.84e-05	0.00019	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TERT—prostate cancer	5.82e-05	0.00019	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KDR—prostate cancer	5.77e-05	0.000188	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAP2K1—prostate cancer	5.73e-05	0.000186	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CD—prostate cancer	5.69e-05	0.000185	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CA—prostate cancer	5.64e-05	0.000183	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SERPINE1—prostate cancer	5.63e-05	0.000183	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ESR1—prostate cancer	5.62e-05	0.000183	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—KRAS—prostate cancer	5.57e-05	0.000181	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HIF1A—prostate cancer	5.57e-05	0.000181	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—BAD—prostate cancer	5.49e-05	0.000179	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGF2—prostate cancer	5.45e-05	0.000177	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LEP—prostate cancer	5.44e-05	0.000177	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CAV1—prostate cancer	5.39e-05	0.000175	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—NOS3—prostate cancer	5.37e-05	0.000175	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KDR—prostate cancer	5.33e-05	0.000173	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APC—prostate cancer	5.32e-05	0.000173	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CG—prostate cancer	5.32e-05	0.000173	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGF—prostate cancer	5.26e-05	0.000171	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IRS1—prostate cancer	5.26e-05	0.000171	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—JAK2—prostate cancer	5.22e-05	0.00017	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ESR1—prostate cancer	5.19e-05	0.000169	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CA—prostate cancer	5.12e-05	0.000167	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—GSK3B—prostate cancer	5.1e-05	0.000166	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MDM2—prostate cancer	5.1e-05	0.000166	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BAD—prostate cancer	5.07e-05	0.000165	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—INS—prostate cancer	5.03e-05	0.000164	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ERBB2—prostate cancer	5.03e-05	0.000164	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CB—prostate cancer	4.96e-05	0.000161	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CREBBP—prostate cancer	4.93e-05	0.00016	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APC—prostate cancer	4.91e-05	0.00016	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CG—prostate cancer	4.91e-05	0.00016	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1—prostate cancer	4.87e-05	0.000158	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGF—prostate cancer	4.85e-05	0.000158	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IRS1—prostate cancer	4.85e-05	0.000158	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—EGFR—prostate cancer	4.84e-05	0.000158	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCL8—prostate cancer	4.77e-05	0.000155	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—GSK3B—prostate cancer	4.71e-05	0.000153	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAP2K1—prostate cancer	4.7e-05	0.000153	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CD—prostate cancer	4.67e-05	0.000152	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1B—prostate cancer	4.66e-05	0.000152	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—INS—prostate cancer	4.64e-05	0.000151	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CA—prostate cancer	4.63e-05	0.000151	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SERPINE1—prostate cancer	4.62e-05	0.00015	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—prostate cancer	4.61e-05	0.00015	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—KRAS—prostate cancer	4.58e-05	0.000149	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CASP3—prostate cancer	4.56e-05	0.000149	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2—prostate cancer	4.56e-05	0.000148	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CREBBP—prostate cancer	4.55e-05	0.000148	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—prostate cancer	4.53e-05	0.000148	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1—prostate cancer	4.49e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGF2—prostate cancer	4.48e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—EGFR—prostate cancer	4.47e-05	0.000146	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCND1—prostate cancer	4.44e-05	0.000145	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NOS3—prostate cancer	4.41e-05	0.000144	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CTNNB1—prostate cancer	4.4e-05	0.000143	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAP2K1—prostate cancer	4.34e-05	0.000141	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CD—prostate cancer	4.31e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MMP9—prostate cancer	4.31e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1A—prostate cancer	4.3e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—JAK2—prostate cancer	4.29e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTEN—prostate cancer	4.29e-05	0.00014	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CA—prostate cancer	4.27e-05	0.000139	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SERPINE1—prostate cancer	4.27e-05	0.000139	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—KRAS—prostate cancer	4.22e-05	0.000137	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CA—prostate cancer	4.2e-05	0.000137	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MDM2—prostate cancer	4.19e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—prostate cancer	4.18e-05	0.000136	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGF2—prostate cancer	4.13e-05	0.000134	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ERBB2—prostate cancer	4.13e-05	0.000134	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EP300—prostate cancer	4.09e-05	0.000133	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CB—prostate cancer	4.07e-05	0.000133	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—NOS3—prostate cancer	4.07e-05	0.000133	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SRC—prostate cancer	3.98e-05	0.000129	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JAK2—prostate cancer	3.96e-05	0.000129	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL8—prostate cancer	3.91e-05	0.000127	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CA—prostate cancer	3.88e-05	0.000126	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—prostate cancer	3.87e-05	0.000126	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MDM2—prostate cancer	3.86e-05	0.000126	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STAT3—prostate cancer	3.83e-05	0.000125	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1B—prostate cancer	3.82e-05	0.000124	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ERBB2—prostate cancer	3.81e-05	0.000124	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—prostate cancer	3.78e-05	0.000123	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CB—prostate cancer	3.76e-05	0.000122	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CASP3—prostate cancer	3.75e-05	0.000122	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2—prostate cancer	3.74e-05	0.000122	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—prostate cancer	3.72e-05	0.000121	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCND1—prostate cancer	3.65e-05	0.000119	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL8—prostate cancer	3.61e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CTNNB1—prostate cancer	3.61e-05	0.000118	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—prostate cancer	3.56e-05	0.000116	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—prostate cancer	3.55e-05	0.000116	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP9—prostate cancer	3.54e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1B—prostate cancer	3.53e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1A—prostate cancer	3.53e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTEN—prostate cancer	3.52e-05	0.000115	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—prostate cancer	3.49e-05	0.000114	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—EGFR—prostate cancer	3.48e-05	0.000113	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CASP3—prostate cancer	3.46e-05	0.000113	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2—prostate cancer	3.45e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—prostate cancer	3.44e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—prostate cancer	3.43e-05	0.000112	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCND1—prostate cancer	3.37e-05	0.00011	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EP300—prostate cancer	3.36e-05	0.000109	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CTNNB1—prostate cancer	3.33e-05	0.000108	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KRAS—prostate cancer	3.29e-05	0.000107	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP9—prostate cancer	3.27e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SRC—prostate cancer	3.26e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1A—prostate cancer	3.26e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTEN—prostate cancer	3.25e-05	0.000106	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—prostate cancer	3.18e-05	0.000103	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—prostate cancer	3.17e-05	0.000103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT3—prostate cancer	3.15e-05	0.000102	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EP300—prostate cancer	3.1e-05	0.000101	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CA—prostate cancer	3.02e-05	9.84e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SRC—prostate cancer	3.01e-05	9.81e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—prostate cancer	2.93e-05	9.55e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—prostate cancer	2.93e-05	9.52e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—prostate cancer	2.93e-05	9.52e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—prostate cancer	2.92e-05	9.5e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT3—prostate cancer	2.91e-05	9.46e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—EGFR—prostate cancer	2.86e-05	9.31e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KRAS—prostate cancer	2.7e-05	8.8e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—prostate cancer	2.7e-05	8.79e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—prostate cancer	2.69e-05	8.77e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—prostate cancer	2.68e-05	8.72e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—EGFR—prostate cancer	2.64e-05	8.6e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KRAS—prostate cancer	2.49e-05	8.12e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CA—prostate cancer	2.48e-05	8.08e-05	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—prostate cancer	2.47e-05	8.04e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—prostate cancer	2.4e-05	7.82e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CA—prostate cancer	2.29e-05	7.46e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—prostate cancer	2.22e-05	7.22e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—prostate cancer	2.2e-05	7.16e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—prostate cancer	2.03e-05	6.61e-05	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—prostate cancer	2.03e-05	6.6e-05	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—prostate cancer	1.87e-05	6.09e-05	CbGpPWpGaD
